Last update 01 Nov 2024

TLL Pharmaceutical, LLC

Private Company

Overview

Related

1
Drugs associated with TLL Pharmaceutical, LLC
Girocitinib
Target
JAK1 x TYK2
Mechanism
JAK1 inhibitors [+1]
Active Org.
Hangzhou Highlightll Pharmaceutical Co., Ltd.Hangzhou Highlightll Pharmaceutical Co., Ltd.
Originator Org.
Hangzhou Highlightll Pharmaceutical Co., Ltd.Hangzhou Highlightll Pharmaceutical Co., Ltd.
Active Indication
Chronic Urticaria [+5]
Inactive Indication
Colitis, Ulcerative [+1]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with TLL Pharmaceutical, LLC
NCT05121402 / WithdrawnPhase 2
A Phase 2 Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of TLL018 for Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis
NCT04243083 / CompletedPhase 1
A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Single and Multiple Ascending Dose (SAD/MAD) Study in Healthy Subjects To Evaluate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Of TLL018 Following Oral Administration And With An Open Label Food Effect Panel
100 Clinical Results associated with TLL Pharmaceutical, LLC
Login to view more data
0 Patents (Medical) associated with TLL Pharmaceutical, LLC
Login to view more data
100 Deals associated with TLL Pharmaceutical, LLC
Login to view more data
100 Translational Medicine associated with TLL Pharmaceutical, LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Girocitinib
 ( JAK1 x TYK2 )		Colitis, Ulcerative
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free